Company Description

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States.

Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus.

The company was incorporated in 1995 and is headquartered in New York, New York.

SIGA Technologies, Inc.

Country	United States
Founded	1995
IPO Date	Sep 9, 1997
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	45
CEO	Diem Nguyen

Contact Details

Address: 31 East 62nd Street New York, New York 10065 United States
Phone	212 672 9100
Website	siga.com

Name	Position
Dr. Diem Nguyen M.B.A., Ph.D.	Chief Executive Officer and Director
Daniel J. Luckshire	Executive Vice President, Chief Financial Officer and Secretary
Dr. Dennis E. Hruby Ph.D.	Executive Vice President and Chief Scientific Officer
Tove C. Bolken	Senior Vice President of Operations and Chief Supply Chain Officer
Herb Vloedman	Senior Vice President and Chief Information Officer
Lawrence R. Miller Esq., J.D.	General Counsel